As the generic of Emend will be applied starting this month, the burden of drug prices for patients is expected to decrease. It is the first time in 15 years that generic for Emend capsule has been reimbursed since the original was listed.

According to industries on the 5th, Acepharma's Atant 80mg and Atant 125mg have been registered as benefits since the 1st of this month. Emend of MSD Korea is used in combination with corticosteroids and 5-HT3 antagonists, and was registered in April 2007.

The 5-HT3 antagonist which ends with Setron is a popular drug. The market size is also large, so generics have also come out a lot in 5-HT3 antagonists.

Aprepitant has not been released